Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma
Clinical trial NCT04197882 · UNKNOWN
Trial details
- NCT number
- NCT04197882
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-27
- Primary completion
- 2021-05-27
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.